TGFBR2 and breast carcinoma: Thus, McEarchern et al. [22] reported that expressing a dominant negative truncated TGF-β type II receptor (TGFBR2) gene in highly metastatic 4T1 murine mammary carcinoma cells significantly restricted their ability to establish distant metastases.